Quest 10 Wealth Builders, Inc. Roivant Sciences Ltd. Transaction History
Quest 10 Wealth Builders, Inc.
- $101 Billion
- Q4 2024
A detailed history of Quest 10 Wealth Builders, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quest 10 Wealth Builders, Inc. holds 858 shares of ROIV stock, worth $9,060. This represents 0.01% of its overall portfolio holdings.
Number of Shares
858Holding current value
$9,060% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
338Shares Held
511MCall Options Held
813KPut Options Held
1.01M-
Qvt Financial LP New York, NY65.8MShares$695 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$655 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$505 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$466 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$374 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.44B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...